Press releases

• Oct 1, 2019Save the date: Calliditas to host Capital Markets Day in Stockholm on November 4, 2019
• Oct 1, 2019Positive interactions with EMA provide route to conditional marketing authorization of lead candidate Nefecon
• Sep 3, 2019Positive feedback from FDA significantly benefits ongoing NefIgArd pivotal Phase 3 study

All press releases

Interim Report Q2 2019

On August 15, 2019, Calliditas Therapeutics published its business update for the second quarter 2019.

• Report
• Presentation
• Press release
• Audio cast

Read the report

Calendar

• Nov 4, 2019Capital Markets Day 2019
• Nov 14, 2019Interim report for the period 1 January – 30 September 2019
• Feb 14, 2020Year-end report for the period 1 January – 31 December 2019

All events